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Neoadjuvant CT Breast Cancer: Why? 
 • Inoperable 
• Inflammatory 
• Stage III – any cN+ 
• Large operable cN0 w favorable biology 
• Very important: pCR correlates w survival 
• There is a metaanalysis statistical trend for favorable 
survival  
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•N=45 patients 
•44 women, 1 man 
•Median age 65 
 
Neoadjuvant CT Breast Cancer 
HVFX 2011-2015: Age 
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HVFX 2011-2015: cT 
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Staging characteristics of relapses or dead women 
Staging characteristics
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HVFX 2011-2015: Conclusion 
•Unfavorable staging still determinant in 
prognosis: tumor burden even w favorable 
biology 
•The five TNBC in the dataset all have had 
DFS or OS events 
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HVFX 2011-2015: Thank you! 
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